Literature DB >> 27567850

The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-β Peptide.

Olga M Selivanova1, Alexey K Surin1,2, Victor V Marchenkov1, Ulyana F Dzhus1, Elizaveta I Grigorashvili1, Mariya Yu Suvorina1, Anna V Glyakina1,3, Nikita V Dovidchenko1, Oxana V Galzitskaya1.   

Abstract

It has been demonstrated using Aβ40 and Aβ42 recombinant and synthetic peptides that their fibrils are formed of complete oligomer ring structures. Such ring structures have a diameter of about 8-9 nm, an oligomer height of about 2- 4 nm, and an internal diameter of the ring of about 3-4 nm. Oligomers associate in a fibril in such a way that they interact with each other, overlapping slightly. There are differences in the packing of oligomers in fibrils of recombinant and synthetic Aβ peptides. The principal difference is in the degree of orderliness of ring-like oligomers that leads to generation of morphologically different fibrils. Most ordered association of ring-like structured oligomers is observed for a recombinant Aβ40 peptide. Less ordered fibrils are observed with the synthetic Aβ42 peptide. Fragments of fibrils the most protected from the action of proteases have been determined by tandem mass spectrometry. It was shown that unlike Aβ40, fibrils of Aβ42 are more protected, showing less ordered organization compared to that of Aβ40 fibrils. Thus, the mass spectrometry data agree with the electron microscopy data and structural models presented here.

Entities:  

Keywords:  Alzheimer’s disease; Aβ42 and Aβ40 peptides; amyloid fibrils; polymorphism; ring-like oligomers

Mesh:

Substances:

Year:  2016        PMID: 27567850     DOI: 10.3233/JAD-160405

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

Review 1.  MIRRAGGE - Minimum Information Required for Reproducible AGGregation Experiments.

Authors:  Pedro M Martins; Susanna Navarro; Alexandra Silva; Maria F Pinto; Zsuzsa Sárkány; Francisco Figueiredo; Pedro José Barbosa Pereira; Francisca Pinheiro; Zuzana Bednarikova; Michał Burdukiewicz; Oxana V Galzitskaya; Zuzana Gazova; Cláudio M Gomes; Annalisa Pastore; Louise C Serpell; Rostislav Skrabana; Vytautas Smirnovas; Mantas Ziaunys; Daniel E Otzen; Salvador Ventura; Sandra Macedo-Ribeiro
Journal:  Front Mol Neurosci       Date:  2020-11-27       Impact factor: 5.639

2.  Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments.

Authors:  Oxana V Galzitskaya; Alexey K Surin; Anna V Glyakina; Vadim V Rogachevsky; Olga M Selivanova
Journal:  J Alzheimers Dis Rep       Date:  2018-10-24

3.  New Model for Stacking Monomers in Filamentous Actin from Skeletal Muscles of Oryctolagus cuniculus.

Authors:  Anna V Glyakina; Alexey K Surin; Sergei Yu Grishin; Olga M Selivanova; Mariya Yu Suvorina; Liya G Bobyleva; Ivan M Vikhlyantsev; Oxana V Galzitskaya
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

4.  Determination of amyloid core regions of insulin analogues fibrils.

Authors:  Alexey K Surin; Sergei Yu Grishin; Oxana V Galzitskaya
Journal:  Prion       Date:  2020-01-01       Impact factor: 3.931

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.